BRCA1 (BReast CAncer Gene 1), a key gene that becomes faulty in some instances, leading to breast and ovarian cancer, plays an important role in the […]
An international collaboration of clinicians, established and led by Professor Chloe Orkin at Queen Mary University of London, has published the first case study series of […]
Patients with a type of breast cancer called HER2-positive are less likely to survive if their initial treatment fails to eradicate the tumor completely and they […]